These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8134661)

  • 1. Immunization of dogs with Q fever vaccines: comparison of phase I, II and phase I CMR Coxiella burnetii vaccines.
    Williams JC; Peacock MG; Race RE
    Rev Elev Med Vet Pays Trop; 1993; 46(1-2):87-94. PubMed ID: 8134661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig abscess/hypersensitivity model for study of adverse vaccination reactions induced by use of Q fever vaccines.
    Wilhelmsen CL; Waag DM
    Comp Med; 2000 Aug; 50(4):374-8. PubMed ID: 11020154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in spleen and thymus cell phenotypes in mice vaccinated with the Coxiella burnetii phase I whole-cell vaccine or the chloroform-methanol residue subunit vaccine.
    Waag DM; Williams JC
    Acta Virol; 1996 Apr; 40(2):87-94. PubMed ID: 8886117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A refined guinea pig model for evaluating delayed-type hypersensitivity reactions caused by Q fever vaccines.
    Ruble DL; Elliott JJ; Waag DM; Jaax GP
    Lab Anim Sci; 1994 Dec; 44(6):608-12. PubMed ID: 7898035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of Q fever cellular and chloroform-methanol residue vaccines as skin test antigens in the sensitized guinea pig.
    Elliott JJ; Ruble DL; Zaucha GM; Jaax GP; Waag DM
    Acta Virol; 1998 Jun; 42(3):147-55. PubMed ID: 9842444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experience in vaccinating farm animals for preventing Q fever in humans].
    Lisák V
    Tr Inst Im Pastera; 1989; 66():143-53, 174. PubMed ID: 2485300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective immunity induced by 67 K outer membrane protein of phase I Coxiella burnetii in mice and guinea pigs.
    Zhang YX; Zhi N; Yu SR; Li QJ; Yu GQ; Zhang X
    Acta Virol; 1994 Dec; 38(6):327-32. PubMed ID: 7793356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaccination with phase I and phase II Coxiella burnetii vaccines in pregnant goats.
    Arricau-Bouvery N; Souriau A; Bodier C; Dufour P; Rousset E; Rodolakis A
    Vaccine; 2005 Aug; 23(35):4392-402. PubMed ID: 16005747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological properties of chloroform/methanol extracts of Coxiella Burnetii.
    Tokarevich NK; Daiter AB; Polotsky YE; Lukácová M; Kazár J; Kartseva NA; Kuzina VA; Efremov VE; Belov AG
    Acta Virol; 1993 Feb; 37(1):29-40. PubMed ID: 8105650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines against coxiellosis and Q fever. Development of a chloroform:methanol residue subunit of phase I Coxiella burnetti for the immunization of animals.
    Williams JC; Peacock MG; Waag DM; Kent G; England MJ; Nelson G; Stephenson EH
    Ann N Y Acad Sci; 1992 Jun; 653():88-111. PubMed ID: 1626897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM; England MJ; Pitt ML
    Vaccine; 1997 Nov; 15(16):1779-83. PubMed ID: 9364683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of Coxiella burnetii whole cells and their outer membrane components.
    Gajdosová E; Kovácová E; Toman R; Skultéty L; Lukácová M; Kazár J
    Acta Virol; 1994 Dec; 38(6):339-44. PubMed ID: 7793358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a killed phase I Coxiella burnetii vaccine in cynomolgus monkeys (Macaca fascicularis).
    Kishimoto RA; Gonder JC; Johnson JW; Reynolds JA; Larson EW
    Lab Anim Sci; 1981 Feb; 31(1):48-51. PubMed ID: 7253550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against Coxiella infection.
    Zhang G; Samuel JE
    Expert Rev Vaccines; 2004 Oct; 3(5):577-84. PubMed ID: 15485337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenicity of chloroform-methanol-treated Coxiella burnetii preparations.
    Kazár J; Schramek S; Lisák V; Brezina R
    Acta Virol; 1987 Mar; 31(2):158-67. PubMed ID: 2886025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity in human volunteers of a chloroform-methanol residue vaccine for Q fever.
    Fries LF; Waag DM; Williams JC
    Infect Immun; 1993 Apr; 61(4):1251-8. PubMed ID: 8454328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Q fever vaccination of sheep: challenge of immunity in ewes.
    Brooks DL; Ermel RW; Franti CE; Ruppanner R; Behymer DE; Williams JC; Stephenson EH
    Am J Vet Res; 1986 Jun; 47(6):1235-8. PubMed ID: 3729123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and immunogenicity of Q fever chloroform:methanol residue (CMR) and phase I cellular (Q-Vax) vaccines in cynomolgus monkeys challenged by aerosol.
    Waag DM; England MJ; Tammariello RF; Byrne WR; Gibbs P; Banfield CM; Pitt ML
    Vaccine; 2002 Jun; 20(19-20):2623-34. PubMed ID: 12057622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and protective ability of corpuscular and soluble vaccines prepared from different Coxiella burnetii phase I strains.
    Kazár J; Gajdosová E; Kovácová E; Valková D
    Acta Virol; 1995 Dec; 39(5-6):243-9. PubMed ID: 8722292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset and duration of immunity in guinea pigs and mice induced with different Q fever vaccines.
    Kazár J; Votruba D; Propper P; Schramek S
    Acta Virol; 1986 Nov; 30(6):499-506. PubMed ID: 2881470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.